CereVasc
Daniel Levangie is an experienced executive with a diverse work history. Daniel is currently serving as the President & CEO of CereVasc since September 2018. Prior to that, they worked as the Managing Partner at ATON Partners from September 2013 to September 2018. Daniel also held the position of CEO at Dune Medical Devices from September 2011 to May 2013 and CEO at Keystone Dental Inc. from March 2009 to March 2011. Earlier in their career, they served as the President & Chief Operating Officer at Cytyc Corporation from 2002 to 2007.
Daniel Levangie attended Northeastern University from 1968 to 1973, where they earned a Bachelor of Science degree in Pharmacy.
This person is not in any teams
CereVasc
CereVasc is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Current treatment of these patients requires an invasive, neurosurgical procedure with a documented rate of success well below the success rate for other neurosurgical interventions. The eShunt System hasthe potential to significantly improve patient outcomes and substantially decrease the overall cost of surgical treatment of this life-threatening condition.